Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-006853
Filing Date
2023-02-03
Accepted
2023-02-03 16:25:14
Documents
1
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3958
  Complete submission text file 0001209191-23-006853.txt   5361
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM
Business Address
Silverman Peter B. (Reporting) CIK: 0001790314 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37773 | Film No.: 23586131